rs63750756

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong

The NM_001377265.1(MAPT):​c.2013T>G​(p.Asn671Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

MAPT
NM_001377265.1 missense

Scores

4
13
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5O:1

Conservation

PhyloP100: 3.03

Publications

270 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • late-onset Parkinson disease
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_001377265.1
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.802
PP5
Variant 17-46010324-T-G is Pathogenic according to our data. Variant chr17-46010324-T-G is described in ClinVar as Pathogenic. ClinVar VariationId is 14253.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001377265.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
NM_001377265.1
MANE Select
c.2013T>Gp.Asn671Lys
missense
Exon 10 of 13NP_001364194.1A0A7I2PJZ2
MAPT
NM_001123066.4
c.1842T>Gp.Asn614Lys
missense
Exon 12 of 15NP_001116538.2P10636-9
MAPT
NM_016835.5
c.1788T>Gp.Asn596Lys
missense
Exon 11 of 14NP_058519.3P10636-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
ENST00000262410.10
TSL:1 MANE Select
c.2013T>Gp.Asn671Lys
missense
Exon 10 of 13ENSP00000262410.6A0A7I2PJZ2
MAPT
ENST00000351559.10
TSL:1
c.837T>Gp.Asn279Lys
missense
Exon 9 of 12ENSP00000303214.7P10636-8
MAPT
ENST00000420682.7
TSL:1
c.750T>Gp.Asn250Lys
missense
Exon 8 of 11ENSP00000413056.2P10636-7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Frontotemporal dementia (2)
2
-
-
not provided (3)
1
-
-
Pick disease;C0338451:Frontotemporal dementia;C1850077:Progressive supranuclear palsy-parkinsonism syndrome;C3160718:Parkinson disease, late-onset;C4551862:Progressive supranuclear ophthalmoplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.81
D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.92
D
M_CAP
Uncertain
0.27
D
MetaRNN
Pathogenic
0.80
D
MetaSVM
Uncertain
0.64
D
MutationAssessor
Benign
1.8
L
PhyloP100
3.0
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-3.7
D
REVEL
Pathogenic
0.74
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.017
D
Polyphen
1.0
D
Vest4
0.62
MutPred
0.77
Gain of catalytic residue at N596 (P = 0.0171)
MVP
1.0
MPC
2.2
ClinPred
0.97
D
GERP RS
5.3
Varity_R
0.74
gMVP
0.94
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs63750756; hg19: chr17-44087690; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.